All stocks ยท KMSMEDI
KM

KMS Medisurgi Limited

KMSMEDI BSE Medical Instruments & Supplies Healthcare

KMS Medisurgi Limited engages in the manufacture and marketing of surgical equipment and wound care products in India, Dubai, Vietnam, Australia, Cambodia, Africa, Philippines, Russia, Pakistan, Europe, Bangladesh, and โ€ฆ

ISIN INE870V01014
Listed โ€”
Quarters tracked โ€”
Filings 14 docs

About

KMS Medisurgi Limited engages in the manufacture and marketing of surgical equipment and wound care products in India, Dubai, Vietnam, Australia, Cambodia, Africa, Philippines, Russia, Pakistan, Europe, Bangladesh, and the United States. The company offers surgical tapes, such as medi, non-woven microporous surgical, surgical paper, transparent surgical, soft gel surgical, soft silicone, silk, and foam tapes, as well as adhesive tapes U.S.P and non woven surgical with acrylic adhesive; surgical dressing, including blister and corn plaster, non adherent foam dressing, non adherent silver dressing, non adherent island dressing, wide area fixation dressing, non woven IV dressing, transparent PU frame style dressing, transparent IV dressing, and hydrocolloid dressing; and theatre incise drape iodine and theatre incise drape. It also provides orthopaedic fiberglass cast; double side tape, foam tape for ECG electrodes, and incise film for drape construction eye drape; and athletic, kinesiology, and pet tape, as well as cohesive bandage. In addition, the company offers beauty products comprising acne patch, breast lift and fashion tape, earring support patch, eyeliner stencil, cannula fixation dressing with pad, frame style iv dressing, makeup shields, and makeup tape rolls. Further, it provides surgical disposables, haemostat and medical devices, as well as urology, surgery, orthopedic/physiotherapy, blood banking, and other surgical equipment. Additionally, the company manufacture and undertake job work of coating of various substrates. KMS Medisurgi Limited was incorporated in 1999 and is headquartered in Mumbai, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in โ€” check back soon.

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 12.2113.9413.8811.0310.327.5110.349.867.327.908.418.89
Expenses 11.3112.9913.0310.079.797.019.689.566.856.957.598.17
Operating Profit 0.900.950.850.960.530.500.660.300.470.950.820.72
OPM % 7.376.816.128.705.146.666.383.046.4212.039.758.10
Other Income 0.010.030.030.020.050.100.000.420.350.170.060.04
Interest 0.110.100.020.000.000.030.070.090.190.270.240.27
Depreciation 0.470.270.250.320.290.330.410.430.450.490.340.41
Profit before tax 0.330.610.610.660.290.240.180.200.180.360.300.08
Tax % 27.2727.8724.5913.6424.1445.8338.8940.0050.0038.8953.3350.00
Net Profit 0.250.440.450.570.220.120.110.120.100.210.140.03
EPS in Rs 0.761.331.361.730.670.360.330.360.300.881.170.60
Dividend Payout % 0.003.753.672.897.5013.7515.0013.7516.505.7125.710.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 3.303.303.303.303.303.303.303.303.302.401.200.50
Reserves 5.014.794.363.933.373.153.052.952.851.122.130.64
Borrowings 0.770.910.540.990.991.031.111.131.912.732.132.85
Other Liabilities 1.471.342.651.512.171.861.643.152.142.362.603.21
Total Liabilities 10.5510.3410.859.739.839.349.1010.5310.208.618.067.20
Fixed Assets 2.931.681.651.821.481.651.812.202.252.691.982.25
CWIP 0.000.000.000.000.000.000.000.000.000.000.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets 7.628.669.207.918.357.697.298.337.955.926.084.95
Total Assets 10.5510.3410.859.739.839.349.1010.5310.208.618.067.20

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 1.510.741.210.46-0.070.53-0.840.75-1.570.90-0.241.35
Cash from Investing Activity -0.61-0.96-0.51-0.66-0.12-0.100.01-0.310.11-1.10-0.030.05
Cash from Financing Activity -0.260.27-0.47-0.01-0.02-0.11-0.06-0.811.571.751.13-1.41
Net Cash Flow 0.640.050.23-0.21-0.210.32-0.88-0.370.101.560.86-0.01
Free Cash Flow -0.210.441.09-0.20-0.190.36-0.860.36-1.58-0.29-0.311.40
CFO/OP % 177.0096.00173.0059.000.00108.00-129.00250.00-309.00106.00-18.00188.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 96.26111.02152.00216.42231.31305.22194.15186.94233.36185.73163.19128.10
Inventory Days 105.1187.1870.9642.4545.45โ€”62.1482.2785.346.2417.7850.02
Days Payable 52.1441.8685.2258.60100.27โ€”70.42134.09134.58139.76141.02155.51
Cash Conversion Cycle 149.23156.34137.74200.27176.49305.22185.86135.12184.1352.2139.9422.61
Working Capital Days 142.29144.01153.84199.54200.54253.22188.85148.07158.079.2430.8121.76
ROCE % 4.878.268.408.313.833.613.373.765.1710.7611.437.70

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 74.42 74.42 74.42 74.42 74.42 74.42 74.42 74.42 74.42 74.42 74.42 74.42
Public 25.57 25.57 25.57 25.57 25.57 25.58 25.58 25.58 25.58 25.58 25.58 25.58
No. of Shareholders 63 64 64 64 67 59 59 59 59 59 59 57

Corporate Actions

10 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Dividend 23 Sep 2025 23 Sep 2025 โ€” 0.05
Dividend 23 Sep 2024 23 Sep 2024 โ€” 0.05
Dividend 22 Sep 2023 23 Sep 2023 โ€” 0.05
Other 22 May 2023 โ€” โ€” โ€” E.G.M.
Dividend 22 Sep 2022 โ€” โ€” 0.05
Dividend 21 Sep 2021 โ€” โ€” 0.05
Dividend 22 Sep 2020 โ€” โ€” 0.05
Dividend 19 Sep 2019 โ€” โ€” 0.05
Dividend 19 Sep 2018 โ€” โ€” 0.05
Dividend 21 Sep 2017 โ€” โ€” 0.05

Announcements

5 filings